AC Immune SA (ACIU) is a publicly traded Healthcare sector company. As of May 21, 2026, ACIU trades at $2.95 with a market cap of $281.91M and a P/E ratio of 0.00. ACIU moved +2.13% today. Year to date, ACIU is -17.90%; over the trailing twelve months it is +65.14%. Its 52-week range spans $1.43 to $4.00. Analyst consensus is strong buy with an average price target of $10.00. Rallies surfaces ACIU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ACIU combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.95 |
| Market Cap | $281.91M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.00 |
| 52-Week Low | $1.43 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover ACIU: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.00.